Should You Sell AMGEN Inc (AMGN) And Go Away This Year?

AMGEN Inc (NASDAQ:AMGN) currently has a daily average trading volume of 3.11M but it saw 2338210 shares traded in last market. With a market cap of 154.33B USD, the company’s current market price of $287.01 came falling about -0.88 while comparing to the previous closing price of $289.57. In past 52 weeks, the stock remained buoying in the range of price level as high as $346.85 and as low as $253.30.

The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Guggenheim which resumed the stock as “Neutral” in its note to investors issued on May 20, 2025, recommending a price target of $288 for it. BofA Securities also issued its recommendations for the stock as it resumed the price target for the stock is $256.

Over the week, AMGN’s stock price is moving 3.09% up while it is 2.48% when we observe its performance for the past one month. Year-to-date it is 10.12% up and over the past year, the stock is showing a downside performance of -6.16%.

Currently, AMGEN Inc’s total number of outstanding shares is 537.70M with 0.22% of that held by the insiders while 83.60% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 9.85% and return on equity (ROE) at 105.67%. It has a price to earnings ratio (P/E ratio) of 26.20 while having a 13.34 of forward P/E ratio. Stock’s beta reads 0.50. Stock has a price to book (P/B) ratio of 24.86 while price to sale or P/S ratio amounts to 4.55. Its return on asset (ROA) is 6.51% on average.

Comet Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.